Cost-effectiveness of cranberry capsules to prevent urinary tract infection in long-term care facilities: economic evaluation with a randomized controlled trial
- PMID: 25180379
- PMCID: PMC4233962
- DOI: 10.1111/jgs.12595
Cost-effectiveness of cranberry capsules to prevent urinary tract infection in long-term care facilities: economic evaluation with a randomized controlled trial
Abstract
Objectives: To investigate whether the preventive use of cranberry capsules in long-term care facility (LTCF) residents is cost-effective depending on urinary tract infection (UTI) risk.
Design: Economic evaluation with a randomized controlled trial.
Setting: Long-term care facilities.
Participants: LTCF residents (N = 928, 703 female, median age 84), stratified according to UTI risk.
Measurements: UTI incidence (clinically or strictly defined), survival, quality of life, quality-adjusted life years (QALYs), and costs.
Results: In the weeks after a clinical UTI, participants showed a significant but moderate deterioration in quality of life, survival, care dependency, and costs. In high-UTI-risk participants, cranberry costs were estimated at €439 per year (1.00 euro = 1.37 U.S. dollar), which is €3,800 per prevented clinically defined UTI (95% confidence interval = €1,300-infinity). Using the strict UTI definition, the use of cranberry increased costs without preventing UTIs. Taking cranberry capsules had a 22% probability of being cost-effective compared with placebo (at a willingness to pay of €40,000 per QALY). In low-UTI-risk participants, use of cranberry capsules was only 3% likely to be cost-effective.
Conclusion: In high-UTI-risk residents, taking cranberry capsules may be effective in preventing UTIs but is not likely to be cost-effective in the investigated dosage, frequency, and setting. In low-UTI-risk LTCF residents, taking cranberry capsules twice daily is neither effective nor cost-effective.
Figures


Comment in
-
Re: Cost-effectiveness of cranberry capsules to prevent urinary tract infection in long-term care facilities: economic evaluation with a randomized controlled trial.J Urol. 2015 Jan;193(1):152-3. doi: 10.1016/j.juro.2014.10.028. Epub 2014 Oct 16. J Urol. 2015. PMID: 25523665 No abstract available.
References
-
- Nicolle LE. Urinary tract infections in the elderly. Clin Geriatr Med. 2009;25:423–436. - PubMed
-
- Foxman B. Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. Am J Med. 2002;113(Suppl 1A):5S–13S. - PubMed
-
- Ruben FL, Dearwater SR, Norden CW, et al. Clinical infections in the noninstitutionalized geriatric age group: Methods utilized and incidence of infections. The Pittsburgh Good Health Study. Am J Epidemiol. 1995;141:145–157. - PubMed
-
- Dwyer LL, Harris-Kojetin LD, Valverde RH, et al. Infections in long-term care populations in the United States. J Am Geriatr Soc. 2013;61:341–349. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical